US 10851158
Biomarkers related to interleukin-33 (IL-33)-mediated diseases and uses thereof
granted A61KA61K2039/505A61K38/1793
Quick answer
US patent 10851158 (Biomarkers related to interleukin-33 (IL-33)-mediated diseases and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K2039/505, A61K38/1793, A61K39/3955, A61K45/06